CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD /
May Mostafa Ramadan
CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD / أمراض الكلى و تأثير فيروسات الدم على وظائفها و تأثير الفيروسات بالدم على إحتياج العقار ايريثروبيوتين فى علاج انيميا الكلى المزمنة May Mostafa Ramadan ; Supervised Nadia Elshamy , Manal Eldeeb - Cairo : May Mostafa Ramadan , 2014 - 111 P. ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
Chronic kidney disease is a worldwide problem , the prevalence of the disease is increasing due to increasing of the patients lifespan and the increasing of the available screening and investigation techniques. The outcome of the disease is related to its early diagnosis and management. Anemia of CKD has many causes. It plays an important role in morbidity, so treatment is important. The management of anemia of CKD which is a complication of ckd due to erythropoietin deficiency is very important and affecting the mortality outcomes of CKD. The management of anemia with oral iron supplementation, intravenous iron, blood transfusion and erythropoietin has their recently guidelines definitions which aims at maintaining haemoglobin concentration > 11 g / dl
CKD CMV Hemoglobin
CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD / أمراض الكلى و تأثير فيروسات الدم على وظائفها و تأثير الفيروسات بالدم على إحتياج العقار ايريثروبيوتين فى علاج انيميا الكلى المزمنة May Mostafa Ramadan ; Supervised Nadia Elshamy , Manal Eldeeb - Cairo : May Mostafa Ramadan , 2014 - 111 P. ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
Chronic kidney disease is a worldwide problem , the prevalence of the disease is increasing due to increasing of the patients lifespan and the increasing of the available screening and investigation techniques. The outcome of the disease is related to its early diagnosis and management. Anemia of CKD has many causes. It plays an important role in morbidity, so treatment is important. The management of anemia of CKD which is a complication of ckd due to erythropoietin deficiency is very important and affecting the mortality outcomes of CKD. The management of anemia with oral iron supplementation, intravenous iron, blood transfusion and erythropoietin has their recently guidelines definitions which aims at maintaining haemoglobin concentration > 11 g / dl
CKD CMV Hemoglobin